Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Emerging Technology
Sapio Sciences launches partnership program
By
LabPulse.com staff writers
Lab informatics platform company Sapio Sciences has launched the Sapio Sciences Partner Program, a network of technology vendors, services companies, and resellers.
July 18, 2024
EnsoData adds Resonea technology to sleep apnea platform
By
LabPulse.com staff writers
EnsoData has acquired sleep diagnostic technology from Resonea that will add acoustic flow and microphone channels to its platform.
July 11, 2024
Proscia 510(k) adds muscle to Siemens Healthineers' Syngo Carbon pathology module
By
Liz Carey
Regulatory approval and integration of Proscia's Concentriq AP-Dx pathology module into Siemens Healthineers' Syngo Carbon digital workspace unlocks new possibilities and efficiency gains for labs, Proscia CEO David West tells
LabPulse.com
.
July 8, 2024
London hospitals grapple with fallout from pathology lab cyberattack
By
LabPulse.com staff writers
South East London Integrated Care System called the situation a level 3 critical incident in relation to a cyberattack that has crippled the pathology laboratory's IT systems and significantly disrupted blood testing services.
June 21, 2024
Labcorp launches clinical trial solutions suite
By
LabPulse.com staff writers
Labcorp has launched Labcorp Global Trial Connect, a suite of digital and data solutions aimed at increasing the speed of clinical trials at investigator sites.
June 20, 2024
Austrian hospitals onboard Sophia Genetics for blood cancer diagnostics
By
LabPulse.com staff writers
The testing will not only help the local population but will provide valuable insights and data to support others using the platform around the world.
June 13, 2024
Analysis: Biomarker testing and targeted therapy underutilized in U.S. NSCLC patients
By
LabPulse.com staff writers
Biomarker testing and targeted therapy is significantly underused for patients with non-small cell lung cancer (NSCLC) in the U.S., according to an analysis of point-of-care real-world data conducted by Amplity Health.
June 10, 2024
Bruker launches new tissue imaging system at ASMS 2024
By
LabPulse.com staff writers
Bruker Corporation has launched its MALDI-TOF/TOF Neoflex Imaging Profiler for mass spectrometry-based tissue imaging, unveiling the new system at the 72nd ASMS meeting.
June 6, 2024
Tempus introduces HER2 and FOLR1 tests for solid tumor cancers
By
LabPulse.com staff writers
Precision medicine firm Tempus has launched two new tests to help identify patients with HER2- or FOLR1-expressing tumors who may be eligible for targeted therapies such as antibody-drug conjugates.
June 3, 2024
Pillar Biosciences gets FDA approval for NGS solid tumor profiling test
By
Matt Limb
Pillar Biosciences has announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its OncoReveal CDx pan-cancer next-generation sequencing (NGS) test for general solid tumor profiling.
April 26, 2024
Roche's breast cancer CDx receives CE Mark
By
LabPulse.com staff writers
Roche has received the CE Mark for the first companion diagnostic (CDx) test to identify patients with HER2-low metastatic breast cancer who may be eligible for treatment with Enhertu.
April 10, 2024
FDA clears another blood-based TBI POC test
By
LabPulse.com staff writers
Abbott furthers its point-of-care (POC) assay for measuring traumatic brain injury biomarkers from whole blood.
April 1, 2024
Page 1 of 52
Next Page